close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Lungpacer Medical USA Inc.

News headline image
Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Announces Health Economic Analysis Demonstrating Clinical and Cost Benefits of AeroPace in Mechanically Ventilated Patients
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Achieves Commercial Milestone as Leading U.S. Hospital Performs First AeroPace® Procedures to Help Patients Liberate from Mechanical Ventilation
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Medical Announces Premarket Approval for AeroPace® System
From Lungpacer Medical USA Inc.
Via GlobeNewswire
News headline image
Lungpacer Medical Announces PMA Submission for AeroPace® System
From Lungpacer Medical USA Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.